The post David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century appeared on BitcoinEthereumNewsThe post David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century appeared on BitcoinEthereumNews

David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century

For feedback or concerns regarding this content, please contact us at [email protected]


Age reversal research could redefine human health, with trials soon to begin on reversing blindness.

Key takeaways

  • Aging is not an inevitable process and can potentially be reversed.
  • People may live into the twenty-second century with the right practices.
  • Reversing aging could lead to cures for diseases like Alzheimer’s, cancer, and heart disease.
  • Understanding and reversing aging could have the biggest impact on human health in history.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • We can safely reset the age of cells by about 75%.
  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • Aging is a universal process that can potentially be reversed, changing our understanding of health.
  • Age reversal research could transform human history.
  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • Advances in longevity research suggest a transformative future for human life expectancy.
  • The potential benefits of aging research underscore its importance in the field of health.

Guest intro

David A. Sinclair, A.O., Ph.D. is a Professor of Genetics in the Department of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for Biology of Aging Research. He co-discovered a cause of aging in yeast and the role of Sir2 in epigenetic changes during his postdoctoral work at MIT. His lab demonstrated that aging can be reversed in animal models to cure blindness.

Why aging is not inevitable

  • — David Sinclair

  • Sinclair challenges the belief that aging is a natural and acceptable process.
  • — David Sinclair

  • Reversing aging could cure major diseases like Alzheimer’s and cancer.
  • — David Sinclair

  • Understanding aging could have the biggest impact on human health in history.
  • — David Sinclair

  • Aging is a universal process that can be potentially reversed, fundamentally changing health perspectives.
  • — David Sinclair

The potential for living into the twenty-second century

  • People may live into the twenty-second century with the right practices.
  • — David Sinclair

  • Advances in longevity research suggest a transformative future for human life expectancy.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • — David Sinclair

  • Age reversal research could transform human history.
  • — David Sinclair

  • The potential benefits of aging research underscore its importance in the field of health.

The role of gene therapy in age reversal

  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • — David Sinclair

  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • — David Sinclair

  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • — David Sinclair

  • Advances in gene therapy could lead to significant breakthroughs in age-related conditions.

Resetting cellular age

  • We can safely reset the age of cells by about 75%.
  • — David Sinclair

  • This process does not regress cells back to zero, which is beneficial.
  • — David Sinclair

  • Understanding cellular age resetting has potential applications in medicine.
  • This claim presents a significant advancement in cellular aging research.
  • Cellular age resetting is central to Sinclair’s research and its potential impact on health.

The information theory of aging

  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • — David Sinclair

  • This theory provides insight into the scientific foundation of Sinclair’s work.
  • Understanding this theory is crucial for grasping the potential to reverse aging.
  • The information theory of aging underpins Sinclair’s confidence in reversing aging.
  • This theory suggests a transformative approach to understanding biological aging.
  • The potential to reverse aging is grounded in a solid scientific framework.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Age reversal research could redefine human health, with trials soon to begin on reversing blindness.

Key takeaways

  • Aging is not an inevitable process and can potentially be reversed.
  • People may live into the twenty-second century with the right practices.
  • Reversing aging could lead to cures for diseases like Alzheimer’s, cancer, and heart disease.
  • Understanding and reversing aging could have the biggest impact on human health in history.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • We can safely reset the age of cells by about 75%.
  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • Aging is a universal process that can potentially be reversed, changing our understanding of health.
  • Age reversal research could transform human history.
  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • Advances in longevity research suggest a transformative future for human life expectancy.
  • The potential benefits of aging research underscore its importance in the field of health.

Guest intro

David A. Sinclair, A.O., Ph.D. is a Professor of Genetics in the Department of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for Biology of Aging Research. He co-discovered a cause of aging in yeast and the role of Sir2 in epigenetic changes during his postdoctoral work at MIT. His lab demonstrated that aging can be reversed in animal models to cure blindness.

Why aging is not inevitable

  • — David Sinclair

  • Sinclair challenges the belief that aging is a natural and acceptable process.
  • — David Sinclair

  • Reversing aging could cure major diseases like Alzheimer’s and cancer.
  • — David Sinclair

  • Understanding aging could have the biggest impact on human health in history.
  • — David Sinclair

  • Aging is a universal process that can be potentially reversed, fundamentally changing health perspectives.
  • — David Sinclair

The potential for living into the twenty-second century

  • People may live into the twenty-second century with the right practices.
  • — David Sinclair

  • Advances in longevity research suggest a transformative future for human life expectancy.
  • Human trials for age reversal technology are set to begin soon, marking a significant milestone.
  • — David Sinclair

  • Age reversal research could transform human history.
  • — David Sinclair

  • The potential benefits of aging research underscore its importance in the field of health.

The role of gene therapy in age reversal

  • The eye is chosen for age reversal studies due to its safety as an enclosed system.
  • — David Sinclair

  • Introducing and activating specific genes can rejuvenate the optic nerve.
  • — David Sinclair

  • Gene therapy plays a crucial role in reversing aging processes in specific tissues.
  • The strategic choice of the eye for initial trials highlights safety considerations.
  • — David Sinclair

  • Advances in gene therapy could lead to significant breakthroughs in age-related conditions.

Resetting cellular age

  • We can safely reset the age of cells by about 75%.
  • — David Sinclair

  • This process does not regress cells back to zero, which is beneficial.
  • — David Sinclair

  • Understanding cellular age resetting has potential applications in medicine.
  • This claim presents a significant advancement in cellular aging research.
  • Cellular age resetting is central to Sinclair’s research and its potential impact on health.

The information theory of aging

  • The biology of aging is understood, and the information theory of aging remains unchallenged.
  • — David Sinclair

  • This theory provides insight into the scientific foundation of Sinclair’s work.
  • Understanding this theory is crucial for grasping the potential to reverse aging.
  • The information theory of aging underpins Sinclair’s confidence in reversing aging.
  • This theory suggests a transformative approach to understanding biological aging.
  • The potential to reverse aging is grounded in a solid scientific framework.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Loading more articles…

You’ve reached the end


Add us on Google

`;
}

function createMobileArticle(article) {
const displayDate = getDisplayDate(article);
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const authorHtml = article.isPressRelease ? ” : `
`;

return `


${captionHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${createSocialShare()}

${authorHtml}
${displayDate}

${article.content}

${article.isPressRelease ? ” : article.isSponsored ? `

Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function createDesktopArticle(article, sidebarAdHtml) {
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const displayDate = getDisplayDate(article);
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const categoriesHtml = article.categories.map((cat, i) => {
const separator = i < article.categories.length – 1 ? ‘|‘ : ”;
return `${cat}${separator}`;
}).join(”);
const desktopAuthorHtml = article.isPressRelease ? ” : `
`;

return `

${categoriesHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${desktopAuthorHtml}
${displayDate}
${createSocialShare()}

${captionHtml}

${article.content}
${article.isPressRelease ? ” : article.isSponsored ? `
Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function loadMoreArticles() {
if (isLoading || !hasMore) return;

isLoading = true;
loadingText.classList.remove(‘hidden’);

// Build form data for AJAX request
const formData = new FormData();
formData.append(‘action’, ‘cb_lovable_load_more’);
formData.append(‘current_post_id’, lastLoadedPostId);
formData.append(‘primary_cat_id’, primaryCatId);
formData.append(‘before_date’, lastLoadedDate);
formData.append(‘loaded_ids’, loadedPostIds.join(‘,’));

fetch(ajaxUrl, {
method: ‘POST’,
body: formData
})
.then(response => response.json())
.then(data => {
isLoading = false;
loadingText.classList.add(‘hidden’);

if (data.success && data.has_more && data.article) {
const article = data.article;
const sidebarAdHtml = data.sidebar_ad_html || ”;

// Check for duplicates
if (loadedPostIds.includes(article.id)) {
console.log(‘Duplicate article detected, skipping:’, article.id);
// Update pagination vars and try again
lastLoadedDate = article.publishDate;
loadMoreArticles();
return;
}

// Add to mobile container
mobileContainer.insertAdjacentHTML(‘beforeend’, createMobileArticle(article));

// Add to desktop container with fresh ad HTML
desktopContainer.insertAdjacentHTML(‘beforeend’, createDesktopArticle(article, sidebarAdHtml));

// Update tracking variables
loadedPostIds.push(article.id);
lastLoadedPostId = article.id;
lastLoadedDate = article.publishDate;

// Execute any inline scripts in the new content (for ads)
const newArticle = desktopContainer.querySelector(`article[data-article-id=”${article.id}”]`);
if (newArticle) {
const scripts = newArticle.querySelectorAll(‘script’);
scripts.forEach(script => {
const newScript = document.createElement(‘script’);
if (script.src) {
newScript.src = script.src;
} else {
newScript.textContent = script.textContent;
}
document.body.appendChild(newScript);
});
}

// Trigger Ad Inserter if available
if (typeof ai_check_and_insert_block === ‘function’) {
ai_check_and_insert_block();
}

// Trigger Google Publisher Tag refresh if available
if (typeof googletag !== ‘undefined’ && googletag.pubads) {
googletag.cmd.push(function() {
googletag.pubads().refresh();
});
}

} else if (data.success && !data.has_more) {
hasMore = false;
endText.classList.remove(‘hidden’);
} else if (!data.success) {
console.error(‘AJAX error:’, data.error);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
}
})
.catch(error => {
console.error(‘Fetch error:’, error);
isLoading = false;
loadingText.classList.add(‘hidden’);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
});
}

// Set up IntersectionObserver
const observer = new IntersectionObserver(function(entries) {
if (entries[0].isIntersecting) {
loadMoreArticles();
}
}, { threshold: 0.1 });

observer.observe(loadingTrigger);
})();

© Decentral Media and Crypto Briefing® 2026.

Source: https://cryptobriefing.com/david-sinclair-aging-can-be-reversed-gene-therapy-is-key-to-rejuvenation-and-we-may-live-into-the-twenty-second-century-the-diary-of-a-ceo/

Market Opportunity
SOON Logo
SOON Price(SOON)
$0,1223
$0,1223$0,1223
-2,78%
USD
SOON (SOON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Stabull’s Expansive Role in the DeFi Ecosystem

Stabull’s Expansive Role in the DeFi Ecosystem

The post Stabull’s Expansive Role in the DeFi Ecosystem appeared on BitcoinEthereumNews.com. A detailed examination of the Stabull protocol reveals its reach extends
Share
BitcoinEthereumNews2026/03/24 07:28
CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
Stablecoin yield in crypto Clarity Act won’t allow rewards on balances, latest text says

Stablecoin yield in crypto Clarity Act won’t allow rewards on balances, latest text says

The post Stablecoin yield in crypto Clarity Act won’t allow rewards on balances, latest text says appeared on BitcoinEthereumNews.com. Crypto industry insiders
Share
BitcoinEthereumNews2026/03/24 06:58